DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2015-09-27T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,7f65d2e7-8252-7c93-f6ea-4e12b56de82c,140,Influenza  seasonal  injectable  preservative free,136.0
2015-09-27T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,7f65d2e7-8252-7c93-f6ea-4e12b56de82c,114,meningococcal MCV4P,136.0
2016-10-02T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,4b41223d-9e56-b391-1429-cd112dc2bcda,140,Influenza  seasonal  injectable  preservative free,136.0
2017-10-08T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,2a5bcb66-3c69-3060-755c-10327bb840a2,140,Influenza  seasonal  injectable  preservative free,136.0
2018-10-14T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,83c2165a-b247-872a-edab-7bdad017602b,140,Influenza  seasonal  injectable  preservative free,136.0
2021-02-21T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,2935219f-c480-613c-0395-291539c81ca8,208,COVID-19  mRNA  LNP-S  PF  30 mcg/0.3 mL dose,136.0
2021-03-14T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,fe0bbe1b-81f6-56b5-8691-124161fe86b1,208,COVID-19  mRNA  LNP-S  PF  30 mcg/0.3 mL dose,136.0
2021-10-17T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,403168f4-5a64-1c86-a918-c7ed085b4b3b,140,Influenza  seasonal  injectable  preservative free,136.0
2021-10-17T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,403168f4-5a64-1c86-a918-c7ed085b4b3b,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2021-10-17T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,403168f4-5a64-1c86-a918-c7ed085b4b3b,43,Hep B  adult,136.0
2021-10-17T03:57:12Z,a676b7df-dbf1-0d6f-c905-15645390017f,403168f4-5a64-1c86-a918-c7ed085b4b3b,114,meningococcal MCV4P,136.0
